Literature DB >> 15482480

Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair.

Aneta Ringholm1, Janis Klovins, Richard Rudzish, Sion Phillips, Jonathan L Rees, Helgi B Schiöth.   

Abstract

Variation in skin color is the major host risk factor for melanoma and other forms of skin cancer. Individuals with red hair show an increased ratio of phaeomelanin to eumelanin in both hair and skin. This ratio is regulated by the melanocortin (MC) 1 receptor. There are several common point mutations in the human MC1 receptor that are overrepresented in North European red-heads, and in individuals with pale skin. In order to determine the functional significance of these mutations, we expressed the Asp84Glu, Val92Met, Arg163Gln, and Asp294His variants of the human MC1 receptors in eukaryotic cells and determined their ability to bind alpha-melanocyte stimulating hormone (MSH) peptides and increase intracellular cAMP. The mutants Asp84Glu and Asp294His showed a much lower response to alpha-MSH in cAMP and a slightly impaired ability to bind alpha-MSH, and the Val92Met mutant bound alpha-MSH with 100-fold lower affinity as compared with the wild-type. The Arg163Gln variant, widely found in some Asian populations, reached normal level of cAMP response but had just slightly lower potency for alpha-MSH in binding and second messenger studies. The results provide important pharmacological characterization of common MC1 receptor variants in various world populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482480     DOI: 10.1111/j.0022-202X.2004.23444.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  30 in total

Review 1.  MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer.

Authors:  Tahseen H Nasti; Laura Timares
Journal:  Photochem Photobiol       Date:  2014-11-07       Impact factor: 3.421

2.  Modeling MC1R rare variants: a structural evaluation of variants detected in a Mediterranean case-control study.

Authors:  Maider Ibarrola-Villava; Maria Peña-Chilet; Marta J Llorca-Cardeñosa; Sara Oltra; Conrado-Martinez Cadenas; Jeronimo Bravo; Gloria Ribas
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

3.  Analysis of MC1R variants in Indian oculocutaneous albinism patients: highlighting the risk of skin cancer among albinos.

Authors:  Mainak Sengupta; Devroop Sarkar; Maitreye Mondal; Swapan Samanta; Asim Sil; Kunal Ray
Journal:  J Genet       Date:  2013       Impact factor: 1.166

Review 4.  GPCR activation: protonation and membrane potential.

Authors:  Xuejun C Zhang; Kening Sun; Laixing Zhang; Xuemei Li; Can Cao
Journal:  Protein Cell       Date:  2013-09-20       Impact factor: 14.870

5.  cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.

Authors:  María Castejón-Griñán; Cecilia Herraiz; Conchi Olivares; Celia Jiménez-Cervantes; Jose Carlos García-Borrón
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

6.  Molecular and functional basis of phenotypic convergence in white lizards at White Sands.

Authors:  Erica Bree Rosenblum; Holger Römpler; Torsten Schöneberg; Hopi E Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

7.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

Review 8.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

9.  The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Authors:  Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

10.  Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Authors:  F Demenais; H Mohamdi; V Chaudru; A M Goldstein; J A Newton Bishop; D T Bishop; P A Kanetsky; N K Hayward; E Gillanders; D E Elder; M F Avril; E Azizi; P van Belle; W Bergman; G Bianchi-Scarrà; B Bressac-de Paillerets; D Calista; C Carrera; J Hansson; M Harland; D Hogg; V Höiom; E A Holland; C Ingvar; M T Landi; J M Lang; R M Mackie; G J Mann; M E Ming; C J Njauw; H Olsson; J Palmer; L Pastorino; S Puig; J Randerson-Moor; M Stark; H Tsao; M A Tucker; P van der Velden; X R Yang; N Gruis
Journal:  J Natl Cancer Inst       Date:  2010-09-28       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.